These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 872499)

  • 1. Effects of prazosin on forearm resistance and capacitance vessels.
    Awan NA; Miller RR; Maxwell K; Mason DT
    Clin Pharmacol Ther; 1977 Jul; 22(1):79-84. PubMed ID: 872499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects.
    Zelis R; Mansour EJ; Capone RJ; Mason DT
    J Clin Invest; 1974 Dec; 54(6):1247-58. PubMed ID: 4612057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.
    Awan NA; Miller RR; Mason DT
    Circulation; 1978 Jan; 57(1):152-9. PubMed ID: 618383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enhanced alpha adrenoreceptor-mediated vasoconstrictor component in essential hypertension].
    Amann FW; Bolli P; Kiowski W; Bühler FR
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1941-4. PubMed ID: 7209472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output.
    Awan NA; Miller RR; Miller MP; Specht K; Vera Z; Mason DT
    Am J Med; 1978 Jul; 65(1):146-54. PubMed ID: 685987
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
    Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nifedipine on forearm vascular resistance and venous capacitance in normal subjects and in patients with congestive heart failure.
    Nakamura Y; Ikeda T; Takata S; Yamamoto M; Kitamura T; Hattori N
    Int J Cardiol; 1985 Sep; 9(1):27-36. PubMed ID: 4044064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prazosin-induced vasodilatation of muscle blood vessels in human hypertension. Evidence from strain-gauge plethysmography. Part I.
    Scarpelli PT; Romano S; Gizdulich P
    Methods Find Exp Clin Pharmacol; 1981; 3(1):9-12. PubMed ID: 7230977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forearm and finger hemodynamics, blood pressure control, and lipid changes in patients with diabetic hypertension treated with atenolol and prazosin.
    Kwan CM; Shepherd AM; Johnson J; Taylor WF
    Clin Pharmacol Ther; 1988 Aug; 44(2):202-10. PubMed ID: 3293875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
    Mehta J; Feldman RL; Nichols WW; Pepine CJ; Conti CR
    Br Heart J; 1980 May; 43(5):556-60. PubMed ID: 7378216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
    Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
    Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of morphine on limb capacitance and resistance vessels.
    Cohen RA; Coffman JD
    Clin Sci (Lond); 1981 Jan; 60(1):5-9. PubMed ID: 7237924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional blood flow response to orthostasis in patients with congestive heart failure.
    Goldsmith SR; Francis GS; Levine TB; Cohn JN
    J Am Coll Cardiol; 1983 Jun; 1(6):1391-5. PubMed ID: 6853896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.
    Thuillez C; Richard C; Richer C; Loueslati H; Perret L; Auzépy P; Giudicelli JF
    J Hypertens Suppl; 1988 Dec; 6(3):S41-3. PubMed ID: 2852235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.